Logo Logo
Group by: Item Type | Date
Jump to: 2019
Number of items: 1.


Doerner, T.; Schulze-Koops, H.; Burmester, G. -R.; Iking-Konert, C.; Schmalzing, M.; Engel, A.; Kaestner, P.; Kellner, H.; Kurthen, R.; Krüger, K.; Rubbert-Roth, A.; Schwenke, H.; Peters, M. A. and Tony, H. -P. (2019): Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI). In: Clinical and Experimental Rheumatology, Vol. 37, No. 6: pp. 937-945

This list was generated on Sun Apr 14 04:10:00 2024 CEST.